All news

A director exercised options at

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Richard A. Heyman, a director at Oric Pharmaceuticals (ORIC), exercised 3,500 options at an exercise price of

Read original source

ORIC company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.